Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan PK in Pediatric HSCT
NCT02390544Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of melphalan in hematologic diseases, sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Pharmacokinetics of Melphalan at 6 hours. Started May 2015; status: completed.
02
Drugs
melphalan
03
Conditions
hematologic diseases
Beyond the preview
Go deeper on NCT02390544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390544.